drug
azelastine hydrochloride
Marketedupdated 3mo agoby Wallace Pharmaceuticals Inc
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 1all catalysts(0)
nothing on the calendar yet
Trials studying azelastine hydrochloride
- phase4Dymista in Chinese Adolescents
- phase2Azelastine Allergen Chamber - Onset of Action Study
- phase1Bioequivalence Study of Azelastine Hydrochloride/ Fluticasone Propionate 137 Microgram/50 Microgram Nasal Spray and Dymista Nasal Spray
- phase2To Investigate Drug-drug Interaction and Relative Bioavailability Between the FDC AzelastineHCL/Beclomethasone Dipropionate Nasal Spray, & Beclomethasone Dipropionate Nasal Spray in the Test Vehicle, and RinoClenil® Nasal Spray
- phase1Study to Compare the Pharmacokinetics of Fixed-Dose Combination of Mometasone + Azelastine Nasal Spray to Mometasone and Azelastine Nasal Sprays in Adolescents and Young Adults With Seasonal Allergic Rhinitis
- phase3Efficacy and Safety Study of AI201901 in Allergic Rhinitis Patients
Patent cliff
source: FDA Orange Bookfirst barrier falls
Jun 4, 2028
~1.8 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (4)
- Jun 4, 2028formulationUS 80710731.8y
- Jun 4, 2028formulationUS 80710731.8y
- Jun 4, 2028formulationUS 80710731.8y
- Jun 4, 2028formulationUS 80710731.8y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 30m ago
Found something off?
comments(0)
5-min edit window · permanent after that